Publicaciones (88) Publicaciones de JOSE PABLO MIRAMONTES GONZALEZ

2023

  1. Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality

    Precision Cancer Medicine

  2. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

    Cancers, Vol. 15, Núm. 17

  3. DRESS syndrome secondary to carbamazepine

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 2, pp. 96-97

  4. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial

    European Journal of Clinical Investigation, Vol. 53, Núm. 1

  5. Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity

    Revista Clinica Espanola, Vol. 223, Núm. 3, pp. 134-143

  6. Effectiveness of Twitter Threads to Improve Medical Student Electrocardiogram (ECG) Reading-Skills. The TwittUVa-ECG Non-Randomized Pre-Post Study

    Medical Science Educator, Vol. 33, Núm. 6, pp. 1359-1369

  7. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  8. Estimands: a new way of interpreting the results of clinical essays

    Spanish Journal of Medicine, Vol. 3, Núm. 1

  9. High cobalamin levels as a five-year risk predictor for developing hematological cancer

    Minerva medica, Vol. 114, Núm. 1, pp. 22-28

  10. Median arcuate ligament syndrome: a rare cause of abdominal pain

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 4, pp. 219-220

  11. Median arcuate ligament syndrome: a rare cause of abdominal pain

    Revista Espanola de Enfermedades Digestivas

  12. Recommendations for the care of patients with cardiovascular disease in health emergency situations: a call to action

    Current Medical Research and Opinion, Vol. 39, Núm. 6, pp. 827-832

  13. Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?»

    Revista Espanola de Geriatria y Gerontologia

  14. Results of semaglutide in patients older than 70 years, a real-world study of efficacy and safety

    MINERVA ENDOCRINOLOGY